Skip to main content
. 2016 Aug 1;26(8):1068–1076. doi: 10.1089/thy.2016.0048

Table 4.

Performance Comparison of Mutational Testing in the Present Study to Published Literature

  Present study Sevem-gene MT ThyroSeq® v2
Sensitivity
 AUS 85% 63% 91%
 FN 100% 57% 90%
Specificity
 AUS 65% 99% 92%
 FN 57% 97% 93%
PPV
 AUS 50% 88% 77%
 FN 63% 87% 83%
NPV
 AUS 91% 94% 97%
 FN 100% 86% 96%
n
 AUS 44 247 98
 FN 12 214 143
Malignancy rate
 AUS 30% 14% 23%
 FN 38% 27% 27%

Performance comparison of mutational testing in the present study to published literature using the same assays: seven-gene mutational test (MT) (11) and ThyroSeq® v2 (16,17).